Literature DB >> 3309007

Doppler mitral pressure half-time: a clinical tool in search of theoretical justification.

J D Thomas1, A E Weyman.   

Abstract

The Doppler determination of the mitral pressure half-time has gained widespread acceptance as a reliable estimate for mitral valve area, despite little theoretical basis for its "independence" of other hemodynamic variables. A simple model of the left atrium and mitral valve has been developed and a governing equation derived from fluid dynamics fundamentals. Solution of this equation indicates that the pressure half-time should vary inversely with mitral valve area, but also proportionally to net left atrial and ventricular compliance and to the square root of the peak transmitral gradient. This complex relation is apparently masked in the typical clinical situation because pressure and compliance tend to change in opposite directions, thereby partly offsetting each other. In several clinical settings, such as balloon mitral valvotomy, left ventricular hypertrophy and aortic regurgitation, changes in initial pressure and compliance may be large enough to alter the relation between mitral area and pressure half-time. This study reviews the development of the pressure half-time concept, presents an overall method for studying mitral valve flow using mathematical modeling and describes the effects of factors other than mitral valve area on pressure half-time.

Entities:  

Mesh:

Year:  1987        PMID: 3309007     DOI: 10.1016/s0735-1097(87)80290-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

1.  Numerical modeling of ventricular filling.

Authors:  J D Thomas; A E Weyman
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

2.  Value of a modified continuity equation method to quantify mitral valve area in patients with mitral stenosis and sinus rhythm.

Authors:  W Voelker; B Regele; H Dittmann; M Schmid; M Mauser; V Kühlkamp; K R Karsch
Journal:  Klin Wochenschr       Date:  1991-12-11

3.  Echocardiographically derived effective valve opening area in mitral prostheses: a comparative analysis of various calculations using continuity equation and pressure half time method.

Authors:  Nikola Bogunovic; Dieter Horstkotte; Lothar Faber; Lukas Bogunovic; Frank van Buuren
Journal:  Heart Vessels       Date:  2015-06-07       Impact factor: 2.037

4.  Limitations of Doppler ultrasound in the assessment of the function of prosthetic mitral valves.

Authors:  J Chambers; G Jackson; D Jewitt
Journal:  Br Heart J       Date:  1990-03

Review 5.  Stenotic lesions.

Authors:  B Wranne; H Baumgartner; F Flachskampf; M Hasenkam; F Pinto
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 6.  Current diagnostic and treatment strategies for Lutembacher syndrome: the pivotal role of echocardiography.

Authors:  Leopold Ndemnge Aminde; Anastase Dzudie; Noah Fongwen Takah; Kathleen Blackett Ngu; Karen Sliwa; Andre Pascal Kengne
Journal:  Cardiovasc Diagn Ther       Date:  2015-04

7.  Doppler measurement of cardiac output across prosthetic mitral valves.

Authors:  H Dittmann; W Voelker; K R Karsch; L Seipel
Journal:  Klin Wochenschr       Date:  1990-03-05

8.  Effect of changes in heart rate on pressure half time in normally functioning mitral valve prostheses.

Authors:  J Chambers; N McLoughlin; A Rapson; G Jackson
Journal:  Br Heart J       Date:  1988-12

9.  Impact of net atrioventricular compliance on clinical outcome in mitral stenosis.

Authors:  Maria Carmo P Nunes; Judy Hung; Marcia M Barbosa; William A Esteves; Vinicius T Carvalho; Lucas Lodi-Junqueira; Cirilo P Fonseca Neto; Timothy C Tan; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2013-10-04       Impact factor: 7.792

10.  Clinical application in routine practice of the proximal flow convergence method to calculate the mitral surface area in mitral valve stenosis.

Authors:  Ahmed Bennis; Abdennasser Drighil; Christophe Tribouilloy; Asmaa Drighil; Nacer Chraibi
Journal:  Int J Cardiovasc Imaging       Date:  2002-12       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.